15.1. Analysis.

Comparison 15: Intermittent oral levetiracetam compared to placebo (any antipyretics), Outcome 1: Recurrent seizure @ 12 months

Comparison 15: Intermittent oral levetiracetam compared to placebo (any antipyretics), Outcome 1: Recurrent seizure @ 12 months